Gamma hydroxybutyric acid (GHB) for the treatment of alcohol dependence: A review

International Journal of Environmental Research and Public Health

Volumn 6, Issue 6, 2009, Pages 1917-1929

  Caputo, Fabio ^a   Vignoli, Teo ^b   Maremmani, Icro ^c   Bernardi, Mauro ^b   Zoli, Giorgio ^a  

^a Azienda Unità Sanitaria Locale Ferrara   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c UNIVERSITY OF PISA   (Italy)

Author keywords

Alcohol withdrawal syndrome; Anti craving drug; Gamma hydroxybutyric acid

Indexed keywords

4 HYDROXYBUTYRIC ACID; CLOMETHIAZOLE; DIAZEPAM; DISULFIRAM; ESCITALOPRAM; METHADONE; NALTREXONE;

ALCOHOL ABSTINENCE; ALCOHOL WITHDRAWAL; ALCOHOLISM; ANXIETY DISORDER; CATALEPSY; CLINICAL TRIAL; COCAINE DEPENDENCE; DEPRESSION; DIZZINESS; DRUG ABUSE; DRUG EFFICACY; DRUG HALF LIFE; DRUG MECHANISM; DRUG METABOLISM; FATIGUE; HEROIN DEPENDENCE; HUMAN; MAINTENANCE THERAPY; MONOTHERAPY; NEUROMODULATION; NONHUMAN; REVIEW; SOMNOLENCE; UNSPECIFIED SIDE EFFECT;

EID: 67649933506     PISSN: None     EISSN: 16604601     Source Type: Journal    
DOI: 10.3390/ijerph6061917     Document Type: Review

References (71)

1. Carter, L.P.; Koek, W.; France, C.P. Behavioral analyses of GHB: receptor mechanisms. Pharmacol. Ther. 2009, 121, 100-114.
2. Gianoulakis, C. Implication of endogenous opioids and dopamine in alcoholism: human and basic science studies. Alcohol Alcoholism 1996, 31, 33-42. (Pubitemid 26150743)
3. Bessmann, S.P.; Fishbein, W.M. Gamma-hydroxybutyric, a normal brain metabolite. Nature 1963, 200, 1207-1208.
4. Laborit, H.; Jouany, J.M.; Gerard, J.; Fabiani, F. Summary of an experimental and clinical study on a metabolic substrate with inhibitory central action: sodium 4-hydroxybutyrate. Presse Medicale 1960, 68, 1867-1869.
5. Benavides, J.; Rumigny, J.F.; Bourguignon, J.J.; Cash, C.; Wermuth, C.G.; Mandel, P.; Vincendon, G.; Maitre, M. High affinity binding sites for gamma-hydroxybutyric acid in rat brain. Life Sci. 1982, 30, 953-961.
6. Snead, O.C.; Liu, C.C. Gamma-hydroxybutyric acid binding sites in rat and human brain synaptosomal membranes. Biochem. Pharmacol. 1984, 33, 2587-2590.
7. Andriamampandry, C.; Taleb, O.; Viry, S.; Muller, C.; Humbert, J.P.; Gobaille, S.; Aunis, D.; Maitre, M. Cloning and characterization of a rat brain receptor that binds the endogenous neuromodulator gamma-hydroxybutyrate (GHB). FASEB J. 2003, 17, 1691-1693.
8. Andriamampandry, C.; Taleb, O.; Kemmel, V.; Humbert, J.P.; Aunis, D.; Maitre, M. Cloning and functional characterization of a gamma-hydroxybutyrate receptor identified in the human brain. FASEB. J. 2007, 21, 885-895. (Pubitemid 46348261)
9. Aldrete, J.A.; Barnes, D.P. 4-Hydroxybutyrate anaesthesia for cardiovascular surgery. A comparison with halothane. Anaesthesia 1968, 23, 558-565.
10. Kleinschmidt, S.; Grundmann, U.; Janneck, U.; Kreienmeyer, J.; Kulosa, R.; Larsen, R. Total intravenous anaesthesia using propofol, gamma-hydroxybutyrate or midazolam in combination with sufentanil for patients undergoing coronary artery bypass surgery. Eur. J. Anaesthesiol. 1997, 14, 590-599.
11. Kleinschmidt, S.; Grundmann, U.; Knocke, T; Silomon, M; Bach, F; Larsen, R. Total intravenous anaesthesia with gamma-hydroxybutyrate (GHB) and sufentanil in patients undergoing coronary artery bypass graft surgery: a comparison in patients with unimpaired and impaired left ventricular function. Eur. J. Anaesthesiol. 1998, 15, 559-564.
12. Kemmel, V.; Miehe, M.; Roussel, G.; Taleb, O.; Nail-Boucherie, K.; Marchand, C.; Stutz, C.; Andriamampandry, C.; Aunis, D.; Maitre, M. Immunohistochemical localization of a GHB receptor-like protein isolated from rat brain. J. Comp. Neurol. 2006, 498, 508-524.
13. Carai, M.A.; Colombo, G.; Brunetti, G.; Melis, S.; Serra, S.; Vacca, G.; Mastinu, S.; Pistuddi, A.M.; Solinas, C.; Cignarella, G.; Minardi, G.; Gessa, G.L. Role of GABAB receptors in the sedative/hypnotic effect of γ-hydroxybutyric acid. Eur. J. Pharmacol. 2001, 428, 315-321.
14. Mamelak, M.; Escrui, J.M.; Stokan, O. The effects of γ- hydroxybutyrate on sleep. Biol. Psychiatry. 1977, 12, 273-278.
15. Mamelak, M.; Scharf, M.B.; Woods, M. Treatment of narcolepsy with gamma-hydroxybutyrate. A review of clinical and sleep laboratory findings. Sleep 1986, 9, 285-289.
16. Carai, M.A.; Colombo, G.; Reali, R.; Serra, S.; Mocci, I.; Castelli, M.P.; Cignarella, G.; Gessa, G.L. Central effects of 1, 4-butanediol are mediated by GABAB receptors via its conversion into γ-hydroxybutyric acid. Eur. J. Pharmacol. 2002, 441, 157-163.
17. Broughton, R.; Mamelak, M. Effects of nocturnal gamma-hydroxybutyrate on sleep/waking patterns in narcolepsy-cataplexy. Can. J. Neurol. Sci. 1980, 7, 23-31.
18. Dauvilliers, Y.; Arnulf, I.; Mignot, E. Narcolepsy with cataplexy. Lancet 2007, 369, 499-511.
19. Tunnicliff, G.; Raess, B.U. Gamma-hydroxybutyrate (orphan medical). Curr. Opin. Investig. Drugs 2002, 3, 278-283.
20. Beghè, F.; Campanini, M.T. Safety and tolerability of gamma-hydroxybutyric acid in the treatment of alcohol-dependents patients. Alcohol 2000, 20, 223-225. (Pubitemid 30408570)
21. Snead, O.C., III; Gibson, K.M. Gamma-hydroxybutyric acid. N. Engl. J. Med. 2005, 352, 2721-2732.
22. Palatini, P.; Tedeschi, L.; Frison, G.; Padrini, R.; Zordan, R.; Orlando, R.; Gallimberti, L.; Gessa, G.L.; Ferrara, S.D. Dose-dependent absorption and elimination of gamma-hydroxybutyric acid in healthy volunteers. Eur. J. Clin. Pharmacol. 1993, 45, 353-356.
23. Ferrara, S.D.; Zotti, S.; Tedeschi, L.; Frison, G.; Castagna, F.; Gallimberti, L.; Gessa, G.L.; Palatini, P. Pharmacokinetics of gamma-hydroxybutyric acid in alcohol dependent patients after single and repeated oral doses. Br. J. Clin. Pharmacol. 1992, 34, 231-235.
24. Ferrara, S.D.; Tedeschi, L.; Frison, G.; Orlando, R.; Mazzo, M.; Zordan, R.; Padrini, R.; Palatini, P. Effect of moderate or severe liver dysfunction on the pharmacokinetics of gammahydroxybutyric acid. Eur. J. Clin. Pharmacol. 1996, 50, 305-310.
25. Davies, M. The role of GABAA receptors in mediating the effects of alcohol in the central nervous system. J. Psychiatry Neurosci. 2003, 28, 263-274. (Pubitemid 37158025)
26. Nie, Z.; Madamba, S.G.; Siggins, G.R. Ethanol inhibits glutamatergic neurotransmission in nucleus accumbens neurons by multiple mechanisms. J. Pharmacol. Exp. Ther. 1994, 271, 1566-1573.
27. Snead, O.C., III; Liu, C.C. GABAA receptor function in the g-hydroxybutyrate model of generalized absence seizures. Neuropharmacology 1993, 32, 401-409.
28. Malcolm, R.J. GABA systems, benzodiazepines, and substance dependence. J. Clin. Psychiatry 2003, 64, 36-40. (Pubitemid 36389870)
29. Leggio, L.; Kenna, G.A.; Swift, R.M. New developments for the pharmacological treatment of alcohol withdrawal syndrome. A focus on non-benzodiazepine GABAergic medications. Prog. Neuropsychopharmacol. Biol. Psychiatry 2008, 32, 1106-1117.
30. Gallimberti, L.; Canton, G.; Gentile, N.; Ferri, M.; Cibin, M.; Ferrara, S.D.; Fadda, F.; Gessa, G.L. Gamma-hydroxybutyric acid for treatment of alcohol withdrawal syndrome. Lancet 1989, 2, 787-789. (Pubitemid 19234820)
31. Addolorato, G.; Balducci, G.; Capristo, E.; Attilia, M.L.; Taggi, F.; Gasbarrini, G.; Ceccanti, M. Gamma-hydroxybutyric acid (GHB) in the treatment of alcohol withdrawal syndrome: a randomized comparative study versus benzodiazepine. Alcohol Clin. Exp. Res. 1999, 23, 1596-1604.
32. Nava, F.; Premi, S.; Manzato, E.; Campagnola, W.; Lucchini, A.; Gessa, G.L. Gammahydroxybutyrate reduces both withdrawal syndrome and hypercortisolism in severe abstinent alcoholics: an open study vs. diazepam. Amer. J. Drug Alcohol Abuse 2007, 33, 379-392. (Pubitemid 47037171)
33. Nimmerrichter, A.A.; Walter, H.; Gutierrez-Lobos, K.E.; Lesch, O.M. Double blind controlled trial of γ-hydroxybutyrate and clomethiazole in the treatment of alcohol withdrawal. Alcohol Alcoholism 2002, 37, 67-73. (Pubitemid 34173312)
34. Korninger, C.; Roller, R.E.; Lesch, O.M. Gamma-hydroxybutyric acid in the treatment of alcohol withdrawal syndrome in patients admitted to hospital. Acta. Med. Austriaca. 2003, 3, 83-86.
35. Agabio, R.; Colombo, G.; Loche, A.; Lobina, C.; Pani, M.L.; Reali, R.; Gessa, G.L. Gammahydroxybutyric acid reducing effect on ethanol intake: evidence in favour of a substitution mechanism. Alcohol Alcoholism 1998, 33, 465-474. (Pubitemid 28477179)
36. Colombo, G.; Agabio, R.; Lobina, C.; Reali, R.; Fadda, F.; Gessa, G.L. Cross tolerance to ethanol and gamma-hydroxybutyric acid. Eur. J. Pharmacol. 1995, 273, 235-238.
37. Gessa, G.L.; Agabio, R.; Carai, M.A.; Lobina, C.; Pani, M.; Reali, R.; Colombo, G. Mechanism of the anti-alcohol effect of gamma-hydroxybutyric acid. Alcohol 2000, 20, 271-276. (Pubitemid 30408576)
38. Biggio, G.; Cibin, M.; Diana, M.; Fadda, F.; Ferara, S.D.; Gallimberti, L.; Gessa, G.L.; Mereu, G.P.; Rossetti, Z.L.; Serra, M. Suppression of voluntary ethanol intake in rats and alcoholics by gamma-hydroxybutyric acid: a non-GABAergic mechanism. Adv. Biochem. Psychopharmacol. 1992, 47, 281-288.
39. Gallimberti, L.; Ferri, M.; Ferrara, S.D.; Fadda, F.; Gessa, G.L. Gamma-hydroxybutyric acid in the treatment of alcohol dependance: a double-blind study. Alcohol. Clin. Exp. Res. 1992, 16, 673-676.
40. Addolorato, G.; Castelli, E.; Stefanini, G.F.; Casella, G.; Caputo, F.; Marsigli, L.; Bernardi, M.; Gasbarrini, G. An open multicentric study evaluating 4-hydroxybutyric acid sodium salt in the medium-term treatment of 179 alcohol dependent subjects. GHB Study Group. Alcohol Alcoholism 1996, 31, 341-345. (Pubitemid 26302563)
41. Addolorato, G.; Cibin, M.; Caputo, F.; Capristo, E.; Gessa, G.L.; Stefanini, G.F.; Gasbarrini, G. Gamma-hydroxybutyric acid in the treatment of alcoholism: dosage fractioning utility in nonresponder alcoholic patients. Drug Alcohol Depend. 1998, 53, 7-10. (Pubitemid 128712675)
42. Maremmani, I.; La Manna, F.; Tagliamone, A. Long-term therapy using GHB (sodium gamma hydroxybutyrate) for treatment-resistant chronic alcoholics. J. Psychoactive Drug. 2001, 33, 135-142. (Pubitemid 32643295)
43. Thai, D.; Dyer, J.E.; Benowitz, N.L.; Haller, C.A. Gamma-hydroxybutyrate and ethanol effects and interactions in humans. J. Clin. Psychopharmacol. 2006, 26, 524-529.
44. Caputo, F.; Addolorato, G.; Lorenzini, F.; Domenicali, M.; Greco, G.; Del Re, A.; Gasbarrini, G.; Stefanini, G.F.; Bernardi, M. Gamma-hydroxybutyric acid versus naltrexone in maintaining alcohol abstinence: an open randomized comparative study. Drug Alcohol Depend. 2003, 70, 85-91. (Pubitemid 36385156)
45. Caputo, F.; Addolorato, G.; Stoppo, M.; Francini, S.; Vignoli, T.; Lorenzini, F.; Del Re, A.; Comaschi, C.; Andreone, P.; Trevisani, F.; Bernardi, M. Comparing and combining gammahydroxybutyric acid (GHB) and naltrexone in maintaining abstinence from alcohol: An open randomised comparative study. Eur. Neuropsychopharmacol. 2007, 17, 781-789.
46. Caputo, F.; Stoppo, M.; Vignoli, T.; Francini, S.; Lorenzini, F.; Bernardi, M. Use of alcohol during the treatment of alcohol dependence with gamma-Hydroxybutyric Acid: Risk of severe events are avoided by the dose fractioning of the drug. J. Clin. Psychopharmacol. 2007, 27, 418.
47. Nava, F.; Premi, S.; Manzato, E.; Lucchini, A. Comparing treatments of alcoholism on craving and bio-chemical measures of alcohol consumptions. J. Psychoactive Drug. 2006, 38, 211-217. (Pubitemid 44759957)
48. Caputo, F.; Vignoli, T.; Lorenzini, F.; Ciuffoli, E.; Del Re, A.; Stefanini, G.F.; Addolorato, G.; Trevisani, F.; Bernardi, M. Alcoholism Treatment Study Group. Suppression of craving for γ-hydroxybutyric acid by naltrexone administration: three case reports. Clin. Neuropharmacol. 2005, 28, 87-89.
49. Stella, L.; Addolorato, G.; Rinaldi, B.; Capuano, A.; Berrino, L.; Rossi, F.; Maione, F. An open randomized study of the treatment of escitalopram alone and combined with γ-hydroxybutyric acidand naltrexone in alcoholic patients. Pharmacol. Res. 2008, 57, 312-317.
50. Verheul, R.; van Den Brink, W.; Geerlings, P. A three-patways psychological model of craving for alcohol. Alcohol Alcoholism 1999, 34, 197-222. (Pubitemid 29213715)
51. Addolorato, G.; Abenavoli, L.; Leggio, L.; Gasbarrini, G. How many cravings? Pharmacological aspects of craving treatment in alcohol addiction: a review. Neuropsychobiology 2005, 51, 59-66. (Pubitemid 40522796)
52. Leggio, L.; Kenna, G.A.; Fenton, M.; Bonenfant, E.; Swift, R.M. Typologies of alcohol dependence from jellinek to genetics and beyond. Neuropsychol. Rev. 2009, doi: 10.1007/s11065-008-9080.
53. Addolorato, G.; Caputo, F.; Capristo, E.; Stefanini, G.F.; Gasbarrini, G. Gamma-hydroxybutyric acid efficacy, potential abuse, and dependence in the treatment of alcohol addiction. Alcohol 2000, 20, 217-222. (Pubitemid 30408569)
54. Caputo, F.; Francini, S.; Stoppo, M.; Lorenzini, F.; Vignoli, T.; Del Re, A.; Comaschi, C.; Leggio, L.; Addolorato, G.; Zoli, G.; Bernardi, M. Incidence of craving for and abuse of gammahydroxybutyric acid (GHB) in different populations of treated alcoholics: an open comparative study. J. Psychopharmacol. 2009, doi: 10.1177/0269881108094620.
55. Kalivas, P.W.; Volkow, N.D. The neural basis of addiction: A pathology of motivation and choice. Am. J. Psychiatry 2005, 162, 1403-1413. (Pubitemid 41105554)
56. Rosen, M.I.; Pearsall, H.R.; Woods, S.W.; Kosten, T.R. Effects of gamma-hydroxybutyric acid (GHB) in opioid-dependent patients. J. Subst. Abuse Treat. 1997, 14, 149-154.
57. Anderson, S.M.; Pierce, R.C. Cocaine-induced alterations in dopamine receptor signalling: implications for reinforcement and reinstatement. Pharmacol. Ther. 2005, 106, 389-403.
58. Volkow, N.D.; Fowler, J.S.; Wang, G.J.; Swanson, J.M. Dopamine in drug abuse and addiction: results from imaging studies and treatment implications. Mol. Psychiatry 2004, 9, 557-569. (Pubitemid 38850435)
59. Xi, Z.X.; Ramamoorthy, S.; Shen, H.; Lake, R.; Samuvel, D.J.; Kalivas, P.W. GABA transmission in the nucleus accumbens is altered after withdrawal from repeated cocaine. J. Neurosci. 2003, 23, 3498-3505. (Pubitemid 36531993)
60. Jayaram, P.; Steketee, J.D. Effects of repeated cocaine on medial prefrontal cortical GABAB receptor modulation of neurotransmission in the mesocorticolimbic dopamine system. J. Neurochem. 2004, 90, 839-847. (Pubitemid 39099965)
61. Martin, T.J.; Kahn, W.R.; Xiao, R.; Childers, S.R. Differential regional effects of methadone maintenance compared to heroin dependence on mu-opioid receptor desensitization in rat brain. Synapse 2007, 61, 176-184. (Pubitemid 46106814)
62. Shi, J.; Zhao, L.Y.; Copersino, M.L.; Fang, Y.X.; Chen, Y.; Tian, J.; Deng, Y.; Shuai, Y.; Jin, J.; Lu, L. PET imaging of dopamine transporter and drug craving during methadone maintenance treatment and after prolonged abstinence in heroin users. Eur. J. Pharmacol. 2007, 28, 160-166.
63. Johnson, B.A.; Swift, R.M.; Addolorato, G.; Ciraulo, D.A.; Myrick, H. Safety and efficacy of GABAergic medications for treating alcoholism. Alcohol. Clin. Exp. Res. 2005, 29, 248-254.
64. Tambour, S.; Quertemont, E. Preclinical and clinical pharmacology of alcohol dependence. Fundam. Clin. Pharmacol. 2007, 21, 9-28.
65. Addolorato, G.; Caputo, F.; Leggio, L.; Vignoli, T.; Abenavoli, L.; Lorenzini, F.; Bernardi, M.; Gasbarrini, G. Gamma hydroxybutyric acid (GHB) withdrawal does not occur at therapeutic dosage. Drug. Alcohol. Depend. 2005, 77, 209.
66. Nicholson, K.L.; Blaster, R.L. GHB: a new and novel drug of abuse. Drug Alcohol Depend. 2000, 63, 1-22.
67. Ricaurte, G.A.; McCann, U.D. Recognition and management of complications of new recreational drug use. Lancet 2005, 365, 2137-2145. (Pubitemid 40826972)
68. Knudsen, K.; Greter, J.; Verdicchio, M. High mortality rates among GHB abusers in Western Sweden. Clin. Toxicol. 2008, 46, 187-192.
69. Caputo, F.; Addolorato, G.; Trevisani, F.; Bernardi, M. Gamma-hydroxybutyrate as a treatment for alcoholism. Lancet 2005, 366, 981-982.
70. Addolorato, G.; Leggio, L.; Ferrulli, A.; Caputo, F.; Gasbarrini, A. The therapeutic potential of gamma-hydroxybutyric acid for alcohol dependence: balancing the risks and benefits. A focus on clinical data. Expert. Opin. Investig. Drug. 2009, 18, 1-12.
71. Caputo, F.; Bernardi, M.; Zoli, G. Treatment of alcohol use disorders. Lancet 2009, 373, 1519.